SCHEMBL23577508

SCHEMBL23577508

CCOC1(c2ccc(C(=O)N3CCC(c4ccc(C(F)(F)F)cc4)CC3)cc2)COC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ MAPK7 Q13164 1/20 0.44
▸ CNR1 P21554 1/20 0.44
▸ HSD11B1 P28845 1/20 0.43
▸ EGLN1 Q9GZT9 1/20 0.43
▸ EPHX2 P34913 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MGLL Q99685 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ FASN P49327 4/20 0.42
▸ TEAD1 P28347 1/20 0.41
▸ PARP10 Q53GL7 1/20 0.41
▸ SLC9A1 P19634 1/20 0.41
▸ LIPE Q05469 1/20 0.41
▸ P2RY14 Q15391 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23577479 0.90 GAA (0.43) GAATDP1MAPK7CNR1HSD11B1
SCHEMBL23577481 0.90 PROKR1 (0.51) TDP1MEN1KMT2AHPGDTSHR
SCHEMBL23605175 0.90 PROKR1 (0.51) TDP1MEN1KMT2AHPGDTSHR
SCHEMBL23577488 0.90 EGLN1 (0.47) GAATDP1MAPK7CNR1HSD11B1
SCHEMBL23577764 0.90 GAA (0.45) GAATDP1MAPK7CNR1HSD11B1
SCHEMBL23577378 0.90 GAA (0.45) GAATDP1MAPK7CNR1HSD11B1
SCHEMBL23577339 0.89 MAPK7 (0.48) GAATDP1MAPK7CNR1HSD11B1
SCHEMBL23577907 0.89 DRD2 (0.46) MAPK7CNR1HSD11B1MGLLPARP10
SCHEMBL23605575 0.89 LIPE (0.37) MAPK7FASNLIPEP2RY14
SCHEMBL23577466 0.89 GAA (0.46) GAATDP1MAPK7CNR1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081509-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA Zydus Lifesciences Limited (IN) 2022-11-02 — — EP claimed
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN claimed
EP-4081509-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA Zydus Lifesciences Limited (IN) 2022-11-02 — — EP disclosed
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN disclosed
WO-2021130723-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA CADILA HEALTHCARE LIMITED (IN) 2021-07-01 — — WO disclosed
Send feedback